Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a common mineral infusion take the sting out of endoscopy?

NCT ID NCT07816848

Symptom relief Sponsor: Hasanuddin University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 14, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

Researchers are testing whether an intravenous infusion of magnesium sulfate reduces esophageal symptoms after upper gastrointestinal endoscopy with biopsy. Sixty adults scheduled for the procedure under general anesthesia receive either magnesium sulfate or a saline placebo. The team measures symptom severity at 1, 4, 24, and 48 hours using a patient questionnaire, and checks blood levels of an inflammation marker before and one hour after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Magnesium sulfate given as an intravenous infusion
What this could lead to
If it helps, magnesium sulfate could become a simple, low-cost way to ease discomfort after endoscopy with biopsy.
What could go wrong
This is a small, single-center study of 60 adults, so any benefit may be modest or may not hold in larger or different groups. Magnesium can cause low blood pressure, flushing, or slowed heart rate, and it is not safe for people with kidney problems or certain heart rhythm conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Mar 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Scheduled to undergo elective upper gastrointestinal endoscopy (UGIE) with mucosal biopsy under general anesthesia. * American Society of Anesthesiologists (ASA) physical status I-III. * Able to provide written informed consent. Exclusion Criteria: * History of hypersensitivity to magnesium sulfate. * Severe renal dysfunction. * Second- or third-degree atrioventricular block. * Neuromuscular disease. * Chronic opioid therapy. * Pregnancy or lactation. * Any condition that could interfere with completion of postoperative assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-endoscopic esophageal symptoms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Procedural

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-endoscopic esophageal symptoms Procedural pain

Contacts and locations

Locations

  • Dr. Wahidin Sudirohusodo Hospital

    Makassar, South Sulawesi, 90221, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.